Arrowstreet Capital
ABCL icon

Arrowstreet Capital’s AbCellera Biologics ABCL Stock Holding History

Arrowstreet Capital’s Portfolio ABCL Stock Details ABCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.16M Buy
+1,039,927
New +$5.08M ﹤0.01% 1152
2026
Q1 		– Sell
-209,925
Closed -$718K – 1813
2025
Q4 		$718K Sell
209,925
-527,020
-72% -$2.35M ﹤0.01% 1619
2025
Q3 		$3.71M Buy
+736,945
New +$3.25M ﹤0.01% 1273
2022
Q4 		– Sell
-327,619
Closed -$3.24M – 1307
2022
Q3 		$3.24M Buy
+327,619
New +$3.59M ﹤0.01% 750

Other funds holding ABCL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return

Arrowstreet Capital's ABCL Position: Q2 2026 in Review

Arrowstreet Capital opened a new position in AbCellera Biologics (ABCL) in Q2 2026: 1,039,927 shares worth $8.16M. The stake represents ﹤0.01% of the portfolio and ranks #1152 among its holdings. This is a return to the name: Arrowstreet Capital previously reported a position in ABCL as recently as Q4 2025.

Arrowstreet Capital first reported a position in ABCL in Q3 2022 and has held it in 4 quarters since. 150 funds tracked by Wall St. Rank hold ABCL as of Q2 2026.

  • Arrowstreet Capital held 1,039,927 shares of AbCellera Biologics worth $8.16M as of Q2 2026.
  • AbCellera Biologics was a new Arrowstreet Capital position in Q2 2026.
  • AbCellera Biologics made up ﹤0.01% of Arrowstreet Capital's portfolio in Q2 2026, its #1152 holding.
  • Arrowstreet Capital first reported a position in AbCellera Biologics in Q3 2022 and has held it in 4 quarters since.
  • 150 funds tracked by Wall St. Rank held AbCellera Biologics as of Q2 2026.

Based on Arrowstreet Capital's 13F filing for Q2 2026, filed 13 Aug 2026.